-
The Rapidly Growing ADC Landscape: Unlocking the Potential of Targeted Cancer Therapies
The field of Antibody-Drug Conjugates (ADCs) is experiencing an unprecedented surge in growth, positioning itself as a high-growth market with immense...
2024-03-29 17:34 -
Expanding Horizons: 1007 Medicines Included in Volume-Based Procurement List
In a significant development for the pharmaceutical industry, a comprehensive volume-based procurement list has been announced, incorporating a stagge...
2024-03-29 17:33 -
Breakthrough in BMS KRAS Inhibitor Study for NSCLC Mutation Reaches Primary Progression-Free Surviva...
In a significant development for the treatment of non-small cell lung cancer (NSCLC), Bristol Myers Squibb (BMS) has announced a major achievement in ...
2024-03-29 17:31 -
Harbour BioMed Achieves Annual Profit for the First Time in 2023: Total Revenue Reaches $89.5 Millio...
Harbour BioMed, a leading biopharmaceutical company, has announced its financial performance for the year 2023. The company achieved a significant mil...
2024-03-29 17:29 -
Latest Developments in National Procurement of Medical Consumables
This article provides a comprehensive overview of the latest updates in the field, highlighting the upcoming batch of procurements and the anticipated...
2024-03-28 16:35 -
Pharmaceutical Giants Clash: State Pharmaceutical vs. China Resources
In a recent development, two pharmaceutical giants, State Pharmaceutical Holdings (国药控股) and China Resources Pharmaceutical Group (华润医药), have...
2024-03-28 14:44 -
Varnotech Biopharm Secures ¥600 Million in Series B Funding for Vaccine Development
Varnotech Biopharm, a leading innovative biotech company focused on vaccine research and development, has recently announced the successful completion...
2024-03-28 14:40 -
Revolutionary Breakthrough: Astellas Claudin18.2 Monoclonal Antibody Approved in Japan
Astellas announced the approval and market launch of their Claudin18.2 antibody, Zolbetuximab (Vyloy), for the treatment of advanced gastric cancer in...
2024-03-28 14:37 -
Saovitinib's New Indication for the Treatment of Non-Small Cell Lung Cancer Accepted for Review in C...
NMPA has accepted the market application for a new indication of Saovitinib, a selective MET inhibitor, for the treatment of locally advanced or metas...
2024-03-28 14:35 -
Multinational Medical Device CEOs Visit China, Signaling Positive Prospects
In a recent development, several CEOs of multinational medical device companies visited China, indicating a positive outlook for the country's healthc...
2024-03-27 15:51
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
- “Europe’s Chemical Industry ... Feb 02, 2026
Related Products
Related Producers
